World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Molecular Biology
USA
2026

D-Index & Metrics

Best Scientists

D-Index
203
Citations
169629
World Ranking
259
National Ranking
170

Molecular Biology

D-Index
195
Citations
157385
World Ranking
22
National Ranking
15

Ira Pastan publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Ira Pastan sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 1,345 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Ira Pastan D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Ira Pastan sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 195 D-Index — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Molecular Biology in United States Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Molecular Biology in United States Leader Award
  • 2024 - Research.com Genetics and Molecular Biology in United States Leader Award
  • 2023 - Research.com Molecular Biology in United States Leader Award
  • 2010 - Member of the National Academy of Medicine (NAM)
  • 1998 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 1992 - Fellow of the American Academy of Arts and Sciences
  • 1982 - Member of the National Academy of Sciences
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Ira Pastan is affiliated with the Center for Cancer Research in the United States. Their research spans multiple disciplines within biomedical sciences, with a primary focus on medicine, biochemistry, genetics and molecular biology, and immunology and microbiology. Their work particularly emphasizes immunology, biotechnology, pulmonary and respiratory medicine, oncology, and radiology, nuclear medicine, and imaging.

The scientist has contributed extensively to topics such as toxin mechanisms and immunotoxins, CAR-T cell therapy research, monoclonal and polyclonal antibodies research, occupational and environmental lung diseases, transgenic plants and applications, cancer research and treatments, and chronic lymphocytic leukemia research.

Significant recent papers authored or co-authored by Ira Pastan include:

  • Immunogenicity of Immunotoxins Containing Pseudomonas Exotoxin A: Causes, Consequences, and Mitigation (2020), published in Frontiers in Immunology
  • Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial (2021), published in Journal of Hematology & Oncology
  • Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin (2020), published in Cancer
  • Multiple proteases are involved in mesothelin shedding by cancer cells (2020), published in Communications Biology
  • Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors (2022), published in Molecular Cancer Therapeutics

Frequent co-authors of Ira Pastan include Raffit Hassan, Robert J. Kreitman, Christine Alewine, Seth M. Steinberg, and Xiufen Liu.

Their research outputs are often published in venues such as:

  • Proceedings of the National Academy of Sciences
  • Journal of Clinical Oncology
  • Molecular Cancer Therapeutics
  • Biomolecules
  • Regular and Young Investigator Award Abstracts

Ira Pastan's professional recognition includes memberships and fellowships in several notable scientific organizations:

  • Member of the National Academy of Sciences (1982)
  • Fellow of the American Academy of Arts and Sciences (1992)
  • Fellow of the American Association for the Advancement of Science (1998)
  • Member of the National Academy of Medicine (2010)
  • Member of the Association of American Physicians

Best Publications

  • Biochemistry of multidrug resistance mediated by the multidrug transporter.

    Michael M. Gottesman;Ira Pastan

  • Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

    Franz Thiebaut;Takashi Tsuruo;Hirofumi Hamada;Michael M. Gottesman

  • Biochemical, cellular, and pharmacological aspects of the multidrug transporter

    Suresh V. Ambudkar;Saibal Dey;Christine A. Hrycyna;Muralidhara Ramachandra

  • Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells

    Chang jie Chen;Janice E. Chin;Kazumitsu Ueda;Douglas P. Clark

  • Expression of a multidrug-resistance gene in human tumors and tissues

    A T Fojo;K Ueda;D J Slamon;D G Poplack

  • Expression of Multidrug Resistance Gene in Human Cancers

    Lori J. Goldstein;Hanan Galski;Antonio Fojo;Mark Willingham

  • The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection

    Cornelia M. Gorman;Glenn T. Merlino;Mark C. Willingham;Ira Pastan

  • Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

    Kazumitsu Ueda;Carol Cardarelli;Michael M. Gottesman;Ira Pastan

  • The multidrug transporter, a double-edged sword.

    M. M. Gottesman;Ira Pastan

  • Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains

    Carmine Carpenito;Michael C. Milone;Raffit Hassan;Jacqueline C. Simonet

  • Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

    Khew-Voon Chin;Kazumitsu Ueda;Ira Pastan;Michael M. Gottesman

  • Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.

    Kai Chang;Ira Pastan

  • Multiple-drug resistance in human cancer.

    I Pastan;M Gottesman

  • Role of cyclic nucleotides in growth control.

    I H Pastan;G S Johnson;W B Anderson

  • Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells.

    H.T. Haigler;F.R. Maxfield;M.C. Willingham;I. Pastan

  • Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.

    Igor B. Roninson;Janice E. Chin;Kyunghee Choi;Philippe Gros

  • Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.

    Franz Thiebaut;Takashi Tsuruo;Hirofumi Hamada;Michael M. Gottesman

  • Direct visualization of binding, aggregation, and internalization of insulin and epidermal growth factor on living fibroblastic cells.

    Joseph Schlessinger;Yoram Shechter;Mark C. Willingham;Ira Pastan

  • Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.

    D.-W. Shen;A. Fojo;J. E. Chin;I. B. Roninson

  • Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein.

    M M Cornwell;I Pastan;M M Gottesman

Frequent Co-Authors

Mark C. Willingham
Mark C. Willingham Wake Forest University
David J. FitzGerald
David J. FitzGerald MRC Laboratory of Molecular Biology
Michael M. Gottesman
Michael M. Gottesman National Institutes of Health
Robert J. Kreitman
Robert J. Kreitman National Cancer Institute
Byungkook Lee
Byungkook Lee National Institutes of Health
Ulrich Brinkmann
Ulrich Brinkmann Roche (Switzerland)
Vijay K. Chaudhary
Vijay K. Chaudhary University of Delhi
Maryalice Stetler-Stevenson
Maryalice Stetler-Stevenson National Institutes of Health
Mitchell Ho
Mitchell Ho Center for Cancer Research
Darell D. Bigner
Darell D. Bigner Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology in the USA can open doors to varied interdisciplinary career options. Many students enhance their credentials by combining biology studies with creative or analytical disciplines. For those interested in the intersection of design and science communication, online graphic design courses provide valuable skills for illustrating research and creating educational materials.

Affordability is a key factor when choosing advanced degrees. If you’re looking for cheap online interdisciplinary studies degree options, you can find flexible programs that let you tailor your coursework to your scientific and professional interests. For those considering a broad knowledge base or career transitions—such as teaching or science writing—the cheapest online masters in history can add context and depth to your understanding of scientific developments.

Additionally, students curious about curating and sharing scientific knowledge may find opportunities in information management. Colleges with library science programs offer pathways to careers in research support, data curation, and science librarianship.

Best Scientists Citing Ira Pastan

Trending Scientists

Recently Published Articles